# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318306-13-000004
Filing Date
2013-03-20
Accepted
2013-03-19 19:00:17
Documents
12
Period of Report
2012-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10K | a10k-123112.htm | 10-K | 1294218
2 | SUBSIDIARIES | ex_21.htm | EX-21 | 3911
3 | AUDITORS CONSENT | ex_23-1.htm | EX-23.1 | 4042
4 | CEO CERTIFICATION | ex_31-1.htm | EX-31.1 | 21164
5 | CFO CERTIFICATION | ex_31-2.htm | EX-31.2 | 21293
6 | CEO - CFO CERTIFICATION | ex_32.htm | EX-3 | 7804
| Complete submission text file | 0000318306-13-000004.txt |  | 8120187

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL INSTANCE DOCUMENTS | accp-20121231.xml | EX-101.INS | 1238363
8 | XBRL TAXONOMY SCHEMA | accp-20121231.xsd | EX-101.SCH | 46660
9 | XBRL CALCULAZTION LINKBASE | accp-20121231_cal.xml | EX-101.CAL | 63868
10 | XBRL DEFINITIVE LINKBASE | accp-20121231_def.xml | EX-101.DEF | 248466
11 | XBRL LABEL LINKBASE | accp-20121231_lab.xml | EX-101.LAB | 697282
12 | XBRL PRESENTATION LINKBASE | accp-20121231_pre.xml | EX-101.PRE | 390555

Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1025
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 13703056
SIC: 2834 Pharmaceutical Preparations